Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

NDI Notification Filed with FDA for NMN Supplied by Nutrition BioTech

11 August 2026 · By · Wire by Fusion42

Published

11 August 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at aol.com →

◆ Verified

Fusion42 · 11 August 2026 · Fusion42 review

Nutrition BioTech has filed a New Dietary Ingredient (NDI) notification with the FDA for NMN, potentially enabling the legal marketing of NMN supplements in the United States.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

Founders in longevity and wellness supplements face a clearer US regulatory pathway for NMN products, unlocking immediate opportunities to enter the market with a compliant ingredient.

◆ Coverage

1 source · 11 Aug 2026

◆ Related on Wire

◆ Topics

Healthnmnndi-notificationfdadietary-supplementsnutrition-biotech